Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Nihonbashi Life Science HUB

Jan 31, 2020 9:30 AM - Jan 31, 2020 8:00 PM

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

DIA Global Oncology Development 2020

Program Committee

  • Toshihiko  Doi, MD, PhD
    Toshihiko Doi, MD, PhD Deputy Director / Chief, Experimental Therapeutics
    National Cancer Center Hospital East, Japan
  • Noboru  Yamamoto, MD, PhD
    Noboru Yamamoto, MD, PhD Deputy Director, Department of Experimental Therapeutics
    National Cancer Center Hospital, Japan
  • Masakazu  Hirata, MD, PhD
    Masakazu Hirata, MD, PhD Clinical Reviewer, Division of RS Consultation, Kansai Branch
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Oncology Medical Science Department, Medical Affairs Division
    Daiichi Sankyo Co., Ltd., Japan
  • Eri  Sekine
    Eri Sekine Executive Vice President
    CMIC Group, Japan
  • Takuya  Suzuki
    Takuya Suzuki Associate Director, Japan anad Asia Clinical Development Department
    Eisai Co., Ltd., Japan
  • Tomoko  Takami
    Tomoko Takami Director, Oncology Clinical Development, Oncology Science Unit
    MSD K.K., Japan
  • Atsushi  Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc Head is Therapeutic Area Strategies
    Daiichi Sankyo, United States
  • Hironobu  Saito, PhD
    Hironobu Saito, PhD Specially Appointed Professor
    Tottori University, Chromosome Egineering Research Center, Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.